ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 125 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,424,433 | -51.5% | 239,332 | -52.6% | 0.04% | -44.9% |
| Q3 2022 | $4,998,000 | -21.8% | 505,234 | -15.8% | 0.07% | -21.6% |
| Q2 2022 | $6,390,000 | +31.1% | 600,000 | +20.0% | 0.09% | +51.7% |
| Q1 2022 | $4,873,000 | -12.8% | 500,000 | +28.0% | 0.06% | -6.5% |
| Q4 2021 | $5,586,000 | -28.7% | 390,700 | 0.0% | 0.06% | -31.1% |
| Q3 2021 | $7,830,000 | +166.1% | 390,700 | +192.0% | 0.09% | +136.8% |
| Q2 2021 | $2,943,000 | – | 133,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
| Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
| Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
| Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
| ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
| Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |